Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1967 1
1968 2
1969 1
1973 1
1974 4
1975 3
1976 2
1977 1
1978 1
1980 1
1981 1
1985 2
1987 2
1990 3
1991 3
1993 4
1994 2
1996 5
1997 2
1998 3
1999 1
2000 1
2001 4
2002 7
2003 6
2004 8
2005 9
2006 9
2007 4
2008 9
2009 9
2010 9
2011 6
2012 11
2013 18
2014 13
2015 16
2016 11
2017 10
2018 10
2019 10
2020 14
2021 17
2022 23
2023 17
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group; Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ. Bridel C, et al. JAMA Neurol. 2019 Sep 1;76(9):1035-1048. doi: 10.1001/jamaneurol.2019.1534. JAMA Neurol. 2019. PMID: 31206160 Free PMC article.
Novel Mitochondria-targeted Drugs for Cancer Therapy.
Fialova JL, Raudenska M, Jakubek M, Kejik Z, Martasek P, Babula P, Matkowski A, Filipensky P, Masarik M. Fialova JL, et al. Mini Rev Med Chem. 2021;21(7):816-832. doi: 10.2174/1389557520666201118153242. Mini Rev Med Chem. 2021. PMID: 33213355 Review.
AADvac1, an Active Immunotherapy for Alzheimer's Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development.
Novak P, Zilka N, Zilkova M, Kovacech B, Skrabana R, Ondrus M, Fialova L, Kontsekova E, Otto M, Novak M. Novak P, et al. J Prev Alzheimers Dis. 2019;6(1):63-69. doi: 10.14283/jpad.2018.45. J Prev Alzheimers Dis. 2019. PMID: 30569088 Review.
Neurofibrillary tau protein pathology is closely associated with the progression and phenotype of cognitive decline in Alzheimer's disease and other tauopathies, and a high-priority target for disease-modifying therapies. ...AADvac1 is currently being investigated in a pha …
Neurofibrillary tau protein pathology is closely associated with the progression and phenotype of cognitive decline in Alzheimer's di …
Effects of diversity in olfactory environment on children's sense of smell.
Martinec Nováková L, Fialová J, Havlíček J. Martinec Nováková L, et al. Sci Rep. 2018 Feb 13;8(1):2937. doi: 10.1038/s41598-018-20236-0. Sci Rep. 2018. PMID: 29440654 Free PMC article.
Diversity in children's everyday olfactory environment may affect the development of their olfactory abilities and odor awareness. ...We controlled for the effects of age and verbal fluency on the children's performance. We found that the children's odor iden …
Diversity in children's everyday olfactory environment may affect the development of their olfactory abilities and odor awareness. .. …
Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences.
Uher T, Adzima A, Srpova B, Noskova L, Maréchal B, Maceski AM, Krasensky J, Stastna D, Andelova M, Novotna K, Vodehnalova K, Motyl J, Friedova L, Lindner J, Ravano V, Burgetova A, Dusek P, Fialova L, Havrdova EK, Horakova D, Kober T, Kuhle J, Vaneckova M. Uher T, et al. Mult Scler. 2023 Oct;29(11-12):1437-1451. doi: 10.1177/13524585231197076. Mult Scler. 2023. PMID: 37840276 Free PMC article.
Low-Level Radon Activity Concentration-A MetroRADON International Intercomparison.
Otahal PPS, Fialova E, Vosahlik J, Wiedner H, Grossi C, Vargas A, Michielsen N, Turtiainen T, Luca A, Wołoszczuk K, Beck TR. Otahal PPS, et al. Int J Environ Res Public Health. 2022 May 10;19(10):5810. doi: 10.3390/ijerph19105810. Int J Environ Res Public Health. 2022. PMID: 35627347 Free PMC article.
Avidity of antineurocytoskeletal antibodies in Alzheimer's disease patients.
Noskova L, Fialova L, Bartos A, Zima T. Noskova L, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Jun;161(2):179-186. doi: 10.5507/bp.2017.017. Epub 2017 Apr 26. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017. PMID: 28452379 Free article.
AIMS: To optimise the ELISA method for the avidity of IgG antibodies against neurofilament heavy chain (NfH) and to determine the levels and avidity of anti-NfH antibodies in patients with Alzheimer's disease (AD) and a healthy control group. METHODS: Various dilutions of …
AIMS: To optimise the ELISA method for the avidity of IgG antibodies against neurofilament heavy chain (NfH) and to determine the levels and …
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.
Kasikova L, Rakova J, Hensler M, Lanickova T, Tomankova J, Pasulka J, Drozenova J, Mojzisova K, Fialova A, Vosahlikova S, Laco J, Ryska A, Dundr P, Kocian R, Brtnicky T, Skapa P, Capkova L, Kovar M, Prochazka J, Praznovec I, Koblizek V, Taskova A, Tanaka H, Lischke R, Mendez FC, Vachtenheim J Jr, Heinzelmann-Schwarz V, Jacob F, McNeish IA, Halaska MJ, Rob L, Cibula D, Orsulic S, Galluzzi L, Spisek R, Fucikova J. Kasikova L, et al. Nat Commun. 2024 Mar 21;15(1):2528. doi: 10.1038/s41467-024-46873-w. Nat Commun. 2024. PMID: 38514660 Free PMC article.
Polypharmacy and Hyperpolypharmacy in Older Individuals with Parkinson's Disease: A Systematic Review and Meta-Analysis.
Bhagavathula AS, Tesfaye W, Vidyasagar K, Fialova D. Bhagavathula AS, et al. Gerontology. 2022;68(10):1081-1090. doi: 10.1159/000521214. Epub 2022 Jan 13. Gerontology. 2022. PMID: 35026767 Free PMC article.
BACKGROUND AND AIM: Polypharmacy (concomitant use of 5-9 medicines) and hyperpolypharmacy (concomitant use of over 10 medicines) were observed to be more frequent in older adults (65 years) and associated with adverse outcomes. Their prevalence and risk in older patients with Par …
BACKGROUND AND AIM: Polypharmacy (concomitant use of 5-9 medicines) and hyperpolypharmacy (concomitant use of over 10 medicines) were observ …
273 results